About CannaPharmaRx, Inc.
CannaPharmaRx, Inc. engages in the research and manufacture of cannabinoid-based pharmaceuticals. It focuses on the treatment of disease states such as neurological disorders, oncology, infectious disease, pain management, inflammatory disease, gastrointestinal disorders, and ophthalmology. The company was founded in August 1998 and is headquartered in Kelowna, Canada.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -0.49$ per share.
The book value per share is 0.33$
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|